Stockscreener 앱 받기
47.06
7.91%
-4.04
시간 외 거래:
47.01
-0.05
-0.11%
전일 마감가:
$51.10
열려 있는:
$51.1
하루 거래량:
848.03K
Relative Volume:
1.15
시가총액:
$1.74B
수익:
$154.15M
순이익/손실:
$-33.58M
주가수익비율:
-49.02
EPS:
-0.96
순현금흐름:
$-20.74M
1주 성능:
+2.86%
1개월 성능:
+22.42%
6개월 성능:
+51.03%
1년 성능:
+29.29%
1일 변동 폭
$46.75
$51.30
1주일 범위
$44.48
$51.30
52주 변동 폭
$20.85
$51.30
Harrow Inc Stock (HROW) Company Profile
명칭
Harrow Inc
전화
615.733.4731
주소
1A BURTON HILLS BLVD, NASHVILLE, CA
HROW을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HROW
Harrow Inc
|
47.06 | 1.89B | 154.15M | -33.58M | -20.74M | -0.96 |
|
ZTS
Zoetis Inc
|
118.66 | 51.85B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.33 | 45.46B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.52 | 42.70B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.79 | 34.62B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
493.99 | 21.03B | 3.08B | 1.24B | 1.07B | 25.61 |
Harrow Inc Stock (HROW) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-11 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-06-12 | 개시 | BTIG Research | Buy |
| 2025-06-10 | 개시 | William Blair | Outperform |
| 2025-02-06 | 개시 | H.C. Wainwright | Buy |
| 2024-12-04 | 재확인 | B. Riley Securities | Buy |
| 2024-04-11 | 개시 | Craig Hallum | Buy |
| 2022-09-08 | 재개 | B. Riley Securities | Buy |
| 2021-10-14 | 재개 | B. Riley Securities | Buy |
| 2021-09-24 | 개시 | Aegis Capital | Buy |
| 2021-07-02 | 개시 | Ladenburg Thalmann | Buy |
모두보기
Harrow Inc 주식(HROW)의 최신 뉴스
Harrow Health stock hits 52-week high at 50.75 USD - Investing.com
Precision Trading with Harrow Health Inc. 11.875% Senior Notes Due 2027 (HROWM) Risk Zones - news.stocktradersdaily.com
Divisadero Street Capital Management LP Takes Position in Harrow, Inc. $HROW - MarketBeat
Aug Closing: Why Harrow Inc stock is favored by pension funds2025 Performance Recap & Daily Entry Point Trade Alerts - moha.gov.vn
Harrow (HROW) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
How the Narrative Surrounding Harrow Is Evolving After Analyst Target Upgrades - Yahoo Finance
Can Harrow Inc. stock deliver strong Q4 earningsLong Setup & Safe Capital Growth Stock Tips - Newser
Panagora Asset Management Inc. Acquires Shares of 47,132 Harrow, Inc. $HROW - MarketBeat
155,465 Shares in Harrow, Inc. $HROW Acquired by Diametric Capital LP - MarketBeat
Harrow (NASDAQ:HROW) Shares Up 10.2%Time to Buy? - MarketBeat
Harrow, Inc. (NASDAQ:HROW) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
How CVS Elevating Vevye To Tier 1 Coverage At Harrow (HROW) Has Changed Its Investment Story - Yahoo Finance
Should Vevye’s CVS Formulary Win Prompt a Closer Look from Harrow (HROW) Investors? - simplywall.st
Harrow: Vevye Replaces Xiidra On Tier 1 Formulary At CVS (NASDAQ:HROW) - Seeking Alpha
Creative Planning Grows Holdings in Harrow, Inc. $HROW - MarketBeat
Harrow, Inc. $HROW Shares Purchased by Geode Capital Management LLC - MarketBeat
Intech Investment Management LLC Sells 6,798 Shares of Harrow, Inc. $HROW - MarketBeat
Insider Sell: Why Harrow Inc. stock appeals to dividend seekersMarket Trend Review & Weekly High Return Stock Opportunities - moha.gov.vn
Market Trends: Is Harrow Inc. stock attractive for income investors - moha.gov.vn
How Harrow Health Inc. 8.625% Senior Notes Due 2026 (HROWL) Affects Rotational Strategy Timing - news.stocktradersdaily.com
Harrow to Present at Two Investor Conferences in December - Sahm
Following a 2.8% Decline Over Last Year, Recent Gains May Please Harrow, Inc. (NASDAQ:HROW) Institutional Owners - 富途牛牛
Is Harrow Inc. stock attractive for income investorsBull Run & Daily Chart Pattern Signal Reports - moha.gov.vn
Private Equity-Style Fund Buys $15.7 Million in Harrow Stock as Revenue Jumps 45% - Yahoo Finance
Penn Capital Unwinds $17.1 Million BGC Stake as Broker Posts 31% Revenue Surge - The Motley Fool
A Fresh Look at Harrow (HROW) Valuation Following Recent Revenue Growth and Long-Term Performance - Yahoo Finance
Why Harrow Inc. stock remains on watchlistsJuly 2025 WrapUp & Daily Entry Point Trade Alerts - newser.com
Health Care Notes: Analysts raise HCA price targets - Nashville Post
Should I hold or sell Harrow Inc. stock in 2025Portfolio Gains Summary & Risk Managed Investment Entry Signals - newser.com
Harrow, Inc. Hits Day High with 7.65% Surge in Strong Intraday Performance - Markets Mojo
How Harrow Inc. stock performs in rising dollar environment2025 AllTime Highs & Risk Controlled Stock Alerts - newser.com
How Harrow Inc. stock reacts to job market dataJuly 2025 Decliners & Weekly Market Pulse Updates - newser.com
What insider trading reveals about Harrow Inc. stockBear Alert & Momentum Based Trading Signals - newser.com
Can Harrow Inc. stock sustain market leadership2025 Price Momentum & AI Enhanced Trading Alerts - newser.com
Harrow, Inc. 2025 Q3ResultsEarnings Call Presentation (NASDAQ:HROW) 2025-11-19 - Seeking Alpha
How Harrow Inc. stock performs in rate cut cyclesEarnings Risk Summary & High Accuracy Trade Signal Alerts - newser.com
Harrow officially acquires Melt Pharmaceuticals - Eyes On Eyecare
Detecting price anomalies in Harrow Inc. with AIJuly 2025 Fed Impact & Consistent Profit Trading Strategies - newser.com
Will Harrow's (HROW) Return to Profitability Reshape Its Growth Narrative? - simplywall.st
Analyzing Harrow Inc. with risk reward ratio charts2025 Biggest Moves & Safe Swing Trade Setups - newser.com
Best data tools to analyze Harrow Inc. stockJuly 2025 PostEarnings & Consistent Return Investment Signals - newser.com
Harrow Completes Its Acquisition of Melt Pharmaceuticals - VisionMonday.com
What analysts say about Harrow Inc stockStock Price Targets & Affordable Growth Investments - earlytimes.in
Will Harrow Inc. stock pay special dividendsMarket Trend Report & Weekly Top Stock Performers List - newser.com
Harrow Inc (HROW) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.48%
0.09%
자본화:
|
볼륨(24시간):